On the Road: Idaho Falls Edition

I’m writing this blog on my way home from Idaho Falls, Idaho, tremendously excited to share with you all the progress being made to engage communities in clinical research. Through NIH’s new ENGAGE initiative, OSP and the NExTRAC are working to create an NIH-wide framework for including public voices in the planning, design, and conduct of clinical research. As part of this effort, OSP is hosting 12 “community conversations” around the country to learn more from individuals, families, and communities about how they think about clinical research – what it is, who is involved, and what it means (or doesn’t mean) to people in their everyday lives.

For the Idaho Falls conversation, folks spent the evening sharing their perspectives on a range of topics, including reflecting on the different types of clinical research studies, the clinical research lifecycle, and how they saw themselves and their communities benefiting from research. We also spent a lot of time digging into how clinical research priorities and study goals are set. It was clear that communities feel that they possess a unique vantage point that should help drive priority setting, which makes sense given that where you live is potentially the biggest driver of your health. Questions about returning “value” from the research conducted in communities was also on the forefront of people’s minds.

I am extremely grateful that people were eager to be candid, expressing a wide range of opinions. Issues sparking conversation ranged from politicization of empirical data, evolving trust in science, importance of mitigating inherent biases, and how to ensure representation and inclusiveness. While individual perspectives varied, there were clear threads of commonalities weaving throughout the conversation, including a genuine interest to find ways to sustain trustworthy relationships with researchers and the government so that we can collectively improve health outcomes for all.

By the end of the evening, folks were cautiously excited: how will NIH turn what we are saying into something with impact? When will we see results? The good news is that OSP has been largely learning from the NIH and Centers who have been doing this for some time. Additionally, if you’ve heard NIH Director, Monica Bertagnolli, you know that meeting patients where they are is one of her top priorities. Just this year, NIH launched the CARE for Health Initiative which works with communities to define the research questions that matter most to them by working with primary care clinics. By embedding these conversations in communities, we can work together to establish a foundation for sustained engagement with communities that are underrepresented in clinical research.

Finally, as I write this post, I am reflecting on how grateful I am to all the Idaho Falls folks (Idahoans, as I learned 😊) who came out to share their stories with us. We are learning so much from communities across the country and I encourage readers to keep tabs on our progress by checking out https://partnersinresearch.nih.gov/community-conversations/. Learning from people with different experiences, perspectives, and circumstances is what policy-making is all about and is necessary for making scientific research, and its outputs, most meaningful and impactful for all.

Lyric Jorgenson, PhD
NIH Associate Director for Science Policy
About Lyric

NIH Office of Science Policy Currently Recruiting for Director of Science Policy Coordination, Collaboration & Reporting Division

The NIH Office of Science Policy seeks an innovative leader to serve as the Director of its Science Policy Coordination, Collaboration & Reporting DivisionThe ideal candidate will have experience working with legislative matters, strong communication skills, and will have led outreach and engagement efforts. 

The position is being advertised as a supervisory GS-15.  The application period is open from today, Thursday, October 31, 2024, until Monday, November 4, 2024.

Current federal employees may apply at: https://www.usajobs.gov/job/816453600

Members of the public should apply at: https://www.usajobs.gov/job/816452000

For more information about the NIH Office of Science Policy, go to https://osp.od.nih.gov/ If you are not yet a subscriber to this listserv, please sign up here.   Also, you can follow us on X: @NIH_OSP

NIH Seeks to Fund Innovative Research and Capacity Building Efforts Related to Bioethics

NIH, through the Office of Science Policy, is announcing the availability of administrative supplements to support research on bioethical issues that either inform future policy directions or augment bioethics research capacity.  For more information, including special areas of interest and application instructions, please visit https://grants.nih.gov/grants/guide/notice-files/NOT-OD-25-015.html.  Applications will be accepted until 5:00pm (applicant local time) on January 24, 2025.

For more information on prior supplements, see here.

Questions about specific IC research priorities should be directed to the contact listed in the notice. 

If you are not yet a subscriber to this listserv, please sign up here.   Also, you can follow us on X: @NIH_OSP and on LinkedIn

Seeking Public Comments on Implementation of “Executive Order on Preventing Access to Americans’ Bulk Sensitive Personal Data and USG-Related Data by Countries of Concern”; DOJ Announces NPRM

In support of the Biden Administration’s effort to protect Americans’ sensitive personal data, the Department of Justice (DOJ) has issued a Notice of Proposed Rulemaking (NPRM) outlining a new national security regulatory program that would prohibit or restrict U.S. persons from engaging in certain categories of data transactions with countries of concern and covered persons. The DOJ welcomes public comment on the NPRM within 30 days of its publication in the Federal Register.

The DOJ rule proposes several categories of potentially restricted data transactions including (i) human Genomic and other human ‘omic Data, (ii) biometric identifiers, (iii) precise geolocation data, (iv) personal health data, (v) personal financial data, (vi) covered personal identifiers, and (vii) government-related data. The DOJ is specifically seeking input on classes of prohibited, restricted, and exempt transactions, thresholds for triggering the proposed rule’s prohibitions, proposed exemption for regulatory approvals and related questions, and other specifics important for effective implementation. 

Questions on the NPRM may be sent to the United States Department of Justice or submitted through https://www.regulations.gov, Docket No. NSD 104.

If you are not yet a subscriber to this listserv, please sign up here.   Also, you can follow us on X: @NIH_OSP